Found 154 Enz. Inhib. hit(s) with Target = 'Catenin beta-1/Protein Wnt-3a' TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 300nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 300nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 300nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 300nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 300nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 300nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 300nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 300nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 300nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 650nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 650nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 650nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 650nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 650nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 650nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 650nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 650nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 650nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 650nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 650nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 650nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 650nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 650nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 2.00E+3nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 2.00E+3nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataIC50: 2.00E+3nMAssay Description:Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: 5nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: 2nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: 100nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: 13nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: 5nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: 192nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: 306nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: 90nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: 7nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: 3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: 31nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: 9nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: 25nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: 6nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: 2.5nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: 10nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER
US Patent
Affinity DataEC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
